CAD 0.4
(-1.25%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 13.14 Million CAD | -4.82% |
2022 | 13.8 Million CAD | 816.22% |
2021 | 1.5 Million CAD | 326.95% |
2020 | -663.96 Thousand CAD | -163.0% |
2019 | 1.05 Million CAD | 2111.03% |
2018 | -52.4 Thousand CAD | 82.55% |
2017 | -300.41 Thousand CAD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | -2.16 Million CAD | -631.59% |
2024 Q1 | -296.25 Thousand CAD | -156.92% |
2023 Q4 | 520.47 Thousand CAD | -73.08% |
2023 Q2 | 3.99 Million CAD | 26.05% |
2023 FY | 1.54 Million CAD | -88.78% |
2023 Q1 | 3.16 Million CAD | 48.84% |
2023 Q3 | 1.93 Million CAD | -51.58% |
2022 Q2 | 3.18 Million CAD | 27.85% |
2022 Q3 | 6 Million CAD | 88.54% |
2022 FY | 13.8 Million CAD | 816.22% |
2022 Q1 | 2.49 Million CAD | 12.31% |
2022 Q4 | 2.12 Million CAD | -64.54% |
2021 FY | 1.5 Million CAD | 326.95% |
2021 Q4 | 2.21 Million CAD | 5227.18% |
2021 Q3 | -43.25 Thousand CAD | 94.16% |
2021 Q2 | -741 Thousand CAD | -1106.3% |
2021 Q1 | 73.63 Thousand CAD | 120.29% |
2020 Q3 | -674.68 Thousand CAD | -153.33% |
2020 Q2 | 1.26 Million CAD | 241.92% |
2020 FY | -663.96 Thousand CAD | -163.0% |
2020 Q1 | -891.52 Thousand CAD | -589.41% |
2020 Q4 | -362.95 Thousand CAD | 46.2% |
2019 FY | 1.05 Million CAD | 2111.03% |
2019 Q4 | 182.16 Thousand CAD | -81.57% |
2019 Q3 | 988.31 Thousand CAD | 515.0% |
2019 Q2 | -238.15 Thousand CAD | -295.83% |
2019 Q1 | 121.61 Thousand CAD | 316.48% |
2018 Q4 | -56.17 Thousand CAD | 60.19% |
2018 FY | -52.4 Thousand CAD | 82.55% |
2018 Q1 | 108.42 Thousand CAD | 133.65% |
2018 Q2 | 199.15 Thousand CAD | 83.68% |
2018 Q3 | -141.09 Thousand CAD | -170.85% |
2017 FY | -300.41 Thousand CAD | 0.0% |
2017 Q4 | -322.23 Thousand CAD | -2937.28% |
2017 Q3 | 11.35 Thousand CAD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Aequus Pharmaceuticals Inc. | 5499.00 CAD | -238866.539% |
CanadaBis Capital Inc. | 11.78 Million CAD | -11.517% |
Decibel Cannabis Company Inc. | 41.85 Million CAD | 68.607% |
Delivra Health Brands Inc. | 6.39 Million CAD | -105.357% |
Entourage Health Corp. | 3.7 Million CAD | -254.419% |
Lifeist Wellness Inc. | 5.34 Million CAD | -145.885% |
Cannara Biotech Inc. | 27.23 Million CAD | 51.743% |
Medicure Inc. | 13.98 Million CAD | 6.064% |
PharmaCielo Ltd. | -1.36 Million CAD | 1059.995% |
BioSyent Inc. | 25.14 Million CAD | 47.735% |
Voyageur Pharmaceuticals Ltd. | -2185.00 CAD | 601508.238% |